@longevitytech.bsky.socialRegenerative platforms reach patients on a different clock – our new report explains why, with MuseCell Innovations clearest case in point.
Link as first comment.
#longevity #regenerative #regenerativemedicine #MuseCell #biotech
@freegardener.bsky.socialAbbVie ships profitable medicines at scale while CRISPR bets on gene editing with no steady revenue. Two risk profiles that don't cancel out. #AbbVie #CRISPR #Biotech #Pharma
https://freegardner.com/sci_scout/abbvie-vs-crispr-therapeutics-pharma-comparison.html
@whiteroseintelligence.comToday's featured profile: @novavax.bsky.social 💉
Novavax is an American biotechnology company based in Gaithersburg, Maryland.
Learn more on the White Rose Wiki: www.whiteroseintelligence.com/novavax/
@skillpad.bsky.socialIt’s the final day of #LifeSciencesFuture 2026!
There’s still time to come meet the Skillpad team & learn more about our digital learning for the #lifesciences industry.
Come say hello—we’d love to meet you!
#DigitalLearning #LifeSciencesTraining #biotech #elearning #training #pharma
@movetheneedlenews.bsky.socialAI helped MIT design heat-stable mRNA vaccines.
Researchers used the AGENT framework to develop formulas that survived 2 months at 37°C. This could transform vaccine delivery in regions without refrigeration.
@proteintech.bsky.socialSpeaker Spotlight
Dr. Stephen Gray, Founder/CEO of NouBio, is combining cellular engineering and AI to industrialize human longevity.
Hear his story at our upcoming webinar.
Register now: https://bit.ly/4hIEX2V
@markfortner.bsky.socialBioMarin lays off 117 California workers to consolidate footprint | #biotech
@ventureradar.bsky.social🧬 Biotech VC Weekly Roundup: precision therapies, immune modulation and computational drug discovery are in focus this week.
We round up the investments you should know about → www.ventureradar.com/articles/Pre...
@ubpharmtox.bsky.socialOur October Alumni Spotlight features Jaqlyn Colangelo, MS, a UB PMY alumna now working at Regeneron.
She shares reflections on moving from grad school to industry, the value of mentorship, and the experiences that shaped her career.
@inkican.bsky.socialWe're getting closer to neuronic tuple processing ...
OR
The future of biotech is BRAAINNS
@growinagri.bsky.socialBoston-based #biotech startup ArkeaBio™ has raised $15 million in a Series A2 funding round led by AgriZeroNZ and supported by Breakthrough Energy to advance its vaccine designed to reduce methane emissions from livestock.
@thedailyfathom.bsky.socialBIOTECH · Lilly's new obesity combo beats its own top drug
Eli Lilly's eloralintide-tirzepatide combo cut up to 23.3% of body weight in a trial, but far more patients quit from side effects.
@drtimos.bsky.socialSignal or noise? > Zealand's stock slides as Boehringer-partnered obesity drug
underwhelms again in phase 3 >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #competitivemarketing #healthcare #pharmaceutical
@iocbtech.bsky.socialLast week, we welcomed a Taiwan BIO delegation to @iocbprague.bsky.social.
Together with i&i Prague and Prague.bio, we introduced the Czech biotech ecosystem, IOCB Prague, and the innovation network around it.
@4040rec.bsky.social#ThursdayMotivation #Thursday #thursdayvibes #ThursdayWisdom #4040rec #medicalsalesjobs #territorysales #commercial #healthcarepartnership #biotech #medtech #lifesciences #healthcare #pharma #businessdevelopment #marketaccess #marketing #firstlinemanagement #peoplemanagement #leadership #consumables
@helpnetsecurity.comGoogle’s SynthID Bio can watermark AI-designed protein binders without breaking them
📖 Read more: www.helpnetsecurity.com/2026/10/01/s...
#cybersecurity #cybersecuritynews #AI #GoogleDeepMind #biosecurity #biotech #syntheticbiology
@drtimos.bsky.socialSignal or noise? > Vertex Pharmaceuticals And 2 Other Top Biotech Stocks To Own
- simplywall.st >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #competitivemarketing #healthcare
@biotechstockdaily.bsky.socialFirst patient enrolled in COMPASSION-37, Akeso's global Phase 3 of cadonilimab in first-line HER2-negative gastric cancer. Comparator: chemotherapy with or without nivolumab.
#GastricCancer #Biotech #Oncology
Disclaimer: This is NOT a financial advice
@drtimos.bsky.socialSignal or noise? > ESMO26: The curious shapes of drug development >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharma #pharmaceutical #biotech #competitivemarketing